Effects of Dopamine Transporter and Receptor Polymorphisms on Smoking Cessation in a Bupropion Clinical Trial

This study examined the role of dopaminergic genes in prospective smoking cessation and response to bupropion treatment in a placebo-controlled clinical trial. Smokers of European ancestry ( N = 418) provided blood samples for genetic analysis and received either bupropion or placebo (10 weeks) plus...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Health psychology 2003-09, Vol.22 (5), p.541-548
Hauptverfasser:	Lerman, Caryn, Shields, Peter G, Wileyto, E. Paul, Audrain, Janet, Hawk, Larry H, Pinto, Angela, Kucharski, Susan, Krishnan, Shiva, Niaura, Ray, Epstein, Leonard H
Format:	Artikel
Sprache:	eng
Schlagworte:	Biological and medical sciences Bupropion Bupropion - therapeutic use Desintoxication. Drug withdrawal District of Columbia Dopamine Dopamine Plasma Membrane Transport Proteins Dopamine Uptake Inhibitors Drug Therapy European Continental Ancestry Group - genetics Female Genetics Human Humans Male Medical sciences Membrane Glycoproteins Membrane Transport Proteins - genetics Nerve Tissue Proteins Neural Receptors New York Placebos Polymorphism Polymorphism, Genetic Psychology. Psychoanalysis. Psychiatry Psychopathology. Psychiatry Receptors, Dopamine D2 - genetics Smoking Cessation Smoking Cessation - ethnology Smoking Cessation - methods Tobacco Smoking Treatments
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!